Home›Stock Screener›Centenial Surgical Suture

Centenial Surgical Suture Share Price Today | Stock Price & Centenial Surgical Suture Share Screener

CSURGSU Medical Equipment
Live Share Price BSE
₹101.00
▼ -1.00 (-0.98%)
2026-10-05 00:00:00

As of October 5, 2026, the live Centenial Surgical Suture share price (BSE: CSURGSU) is ₹101.00, down 0.98% from the previous close, with shares trading between ₹97.00 and ₹101.00 in today's trading session, and a 52-week range of ₹73.04–₹114.15. Check CSURGSU 52-week performance for the annual price range and momentum. Use the Centenial Surgical Suture stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Centenial Surgical Suture opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹56 and net income of ₹-1, with EBITDA of ₹6, an operating margin of 11.0% and a profit margin of -1.8%.

Centenial Surgical Suture Market Cap ₹36.84 Cr.
CSURGSU P/E Ratio (TTM) -25.76
Centenial Surgical Suture P/B Ratio 1.39
EPS (TTM) ₹-6.04
Dividend Yield -
Debt to Equity 0.97
CSURGSU 52 Week High ₹114.15
Centenial Surgical Suture 52 Week Low ₹73.04
Operating Margin 11.00%
Profit Margin -1.79%
CSURGSU Revenue (TTM) ₹56.00
EBITDA ₹6.00
Net Income ₹-1.00
Total Assets ₹80.00
Total Equity ₹29.00

Centenial Surgical Suture Share Price Chart

Track the current stock price of Centenial Surgical Suture with an interactive chart. Analyse CSURGSU share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Centenial Surgical Suture stock quote in one place.

The quote of ₹101.00 sits between the 52-week low of ₹73.04 and the 52-week high of ₹114.15, and the latest session moved -0.98% from the previous close.

Centenial Surgical Suture Company Profile - Fundamental Screener

Screen Centenial Surgical Suture company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CSURGSU shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Medical Equipment industry, and it trades under ISIN INE405H01018.

Company Details

Classification

Sector Healthcare
Industry Medical Equipment
Sub-Sector Medical Equipment
Segment E

Identifiers and Leadership

ISIN INE405H01018

Centenial Surgical Suture Balance Sheet Screener

Screen CSURGSU balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹80, down from ₹85 in 2025.

Latest statistics put total assets at ₹80 and shareholder funds at ₹29, with a leverage ratio of 0.97.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 80 85 79 66 61 70 69 57 55 56
Current Assets 60 63 65 59 53 61 58 52 51 52
Fixed Assets 18 20 13 7 8 9 10 4 4 4

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 20 22 14 6 7 9 10 3 3 3
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 29 31 32 31 30 30 29 28 26 25
Share Capital 5 5 5 5 5 5 5 5 5 5
Reserves & Surplus 23 25 27 26 25 24 23 23 21 19

Centenial Surgical Suture Income Statement Screener - Profit & Revenue Analysis

Screen Centenial Surgical Suture income statement and profit fundamentals. Analyze CSURGSU quarterly results. Centenial Surgical Suture reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹56 and net profit was ₹-1, equal to earnings per unit of ₹-4.00, at an operating margin of 11%.

In that period expenses were ₹50, interest cost ₹3 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹54 and net profit of ₹-2.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 56 54 54 51 53 45 37 56 56 53 53 52 52
Expenses 50 49 47 46 48 40 32 50 51 48 48 47 47

Operating Costs and Margins

EBITDA 6 5 6 5 4 5 5 6 5 5 5 5 5
Operating Profit % 11.00% 9.00% 12.00% 10.00% 8.00% 10.00% 14.00% 10.00% 9.00% 8.00% 9.00% 9.00% 10.00%
Depreciation 4 4 4 1 1 2 2 2 1 1 1 1 1
Interest 3 3 4 3 2 2 2 2 2 1 2 2 2

Profit and Earnings

Profit Before Tax -1 -2 -2 1 2 1 2 2 3 2 3 2 3
Tax 1 0 0 0 1 0 1 1 1 1 1 1 1
Net Profit -1 -2 -2 1 1 1 1 1 2 2 2 2 2
EPS -4.00 -6.04 -4.01 3.11 2.43 1.72 2.64 3.55 5.53 4.23 4.71 4.28 5.25

Centenial Surgical Suture Cash Flow Screener - Liquidity Fundamentals

Screen CSURGSU cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹7.

Over the same period, investing activities used ₹2 and financing activities used ₹5.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 7 17 6 1 5 2 2 2 2 0
Investing Activities -2 -12 -8 0 0 -1 -1 -1 -1 -2

Financing and Net Cash

Financing Activities -5 -6 2 -1 -5 -1 0 -1 -1 2
Net Cash Flow 0 -1 0 0 0 0 0 -1 0 0

Centenial Surgical Suture Shareholding Pattern Screener

See Centenial Surgical Suture shareholding pattern with promoter, FII, and DII holdings. Check Centenial Surgical Suture promoter holding and ownership changes for CSURGSU on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 46.89%, foreign institutions 0.00%, domestic institutions 0.00% and the public 50.69%, spread across 1,182 shareholders.

The shareholder count was 1,182 in 2026-Mar, compared with 1,165 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 46.89% 46.89% 46.89% 46.89% 46.89% 46.89% 46.89% 46.89%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 50.69% 50.71% 50.29% 50.29% 50.64% 50.70% 51.68% 50.21%
Other Holding 2.43% 2.40% 2.83% 2.82% 2.47% 2.41% 1.43% 2.90%
Shareholder Count 1,182 1,165 1,206 1,186 1,193 1,200 1,072 1,159

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Centenial Surgical Suture. Centenial Surgical Suture dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Centenial Surgical Suture.

Centenial Surgical Suture Stock Index Membership - Nifty & Sensex

See which indices include Centenial Surgical Suture stock. Check CSURGSU index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Centenial Surgical Suture is not part of any tracked indices.
Only major market indices are tracked in our system.

Centenial Surgical Suture Market Events Screener - Corporate Actions

Get Centenial Surgical Suture corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Centenial Surgical Suture stock events that may affect CSURGSU share price, along with derivatives, futures and options activity and sector gainers.

11 corporate actions are listed, the most recent entry being Annual General Meeting dated September 28, 2026, with a record date of September 28, 2026.

It is followed by Quarterly Result Announcement dated August 14, 2026 and Quarterly Result Announcement dated May 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-28 2026-09-28 Annual General Meeting NA 21.81%
2026-08-14 2026-08-14 Quarterly Result Announcement NA 12.44%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 0.99%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 9.51%
2025-11-13 2025-11-13 Quarterly Result Announcement NA 3.62%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 5.12%
2025-07-28 2025-07-28 Annual General Meeting NA 9.28%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 1.32%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -10.16%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -8.02%
2024-09-27 2024-09-27 Annual General Meeting NA 19.91%

Centenial Surgical Suture Competitors Screener - Peer Stocks Comparison

Screen CSURGSU competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Poly Medicure 16,417 53.07 1,995 13.43% 321 37.07
Tarsons Products 1,787 157.15 447 9.38% 14 54.81
Q-Line Biotech 1,548 27.67 347 7.89% 56 53.63
Laxmi Dental 1,049 34.47 286 18.15% 26 39.36
Hemant Surgical Industries 900 48.80 238 112.99% 18 74.44
Vasa Denticity 813 70.51 283 12.77% 10 72.24
Osel Devices 651 22.45 295 57.88% 29 43.65
Fabtech Technologies 631 13.05 411 22.29% 36 36.48
Prevest Denpro 458 20.83 77 14.31% 21 48.45
QMS Medical Allied Services 359 30.06 174 10.27% 12 56.67

Centenial Surgical Suture Company Announcements - News & Reports Screener

Screen CSURGSU latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 29, 2026.

The next most recent announcements are dated September 29, 2026 and September 19, 2026.

Date Update Actions
2026-09-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-19 Closure of Trading Window -
2026-09-11 Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) -
2026-09-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-01 Reg. 34 (1) Annual Report. -
2026-09-01 Intimation Of AGM & Submission Of Notice Of 31St AGM To Be Held On Monday September 28 2026 -
2026-09-01 Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015 In Terms Of The Requirements Of Regulation 36(1)(B) - Letter Issued To Non-Emailholders Providing The Web-Link From Where The Notice Of 31St AGM & Annual Report For The FY 2025-26 -
2026-08-26 Price Of The Scrip Of Our Company Has Seen An Abnormal Price Rise -
2026-08-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-14 Intimation Of 31St Annual General Meeting (AGM) Of The Company Cut-Off Date For Voting And E-Voting As Per Regulation 44 Of The SEBI (Listing Obligations And Disclosures Requirements [LODR]) Regulations 2015. -
2026-08-14 Notice Of Book Closure As Per Regulation 42 Of The SEBI (Listing Obligations And Disclosures Requirements [LODR]) Regulations 2015 For The Purpose Of 31St Annual General Meeting (E-AGM) To Be Held On September 28 2026 -
2026-08-14 Re-Appointment Of Whole Time Director Of The Company - Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (The SEBI Listing Regulation). -
2026-08-14 Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) -
2026-08-14 Intimation Of Appointment Of Internal Auditor - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-08-14 Approval Of Standalone Un-Audited Financial Results For The Quarter Ended June 30 2026 -
2026-08-14 Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday August 14 2026 Pursuant To Regulation 30 Read With Schedule III(A)(IV) Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations 2015. -
2026-08-03 Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter Ended June 30 2026 -
2026-07-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-24 Announcement under Regulation 30 (LODR)-Change in Management -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹101.00, within a 52-week range of ₹73.04 to ₹114.15. The P/E ratio is -25.76 and the P/B ratio is 1.39, with earnings per unit of ₹-6.04. Market capitalisation stands at ₹36.84 Cr. The company operates in the Healthcare sector, in the Medical Equipment industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.